Frank van Leth

Associate Professor Health Sciences

Risk of Tuberculosis after Antiretroviral Treatment Initiation: A Comparison between Efavirenz and Nevirapine Using Inverse Probability Weighting


Journal article


S. Hermans, Y. Manabe, A. Kiragga, A. Hoepelman, J. Lange, F. van Leth
Antiviral Therapy, 2013

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Hermans, S., Manabe, Y., Kiragga, A., Hoepelman, A., Lange, J., & van Leth, F. (2013). Risk of Tuberculosis after Antiretroviral Treatment Initiation: A Comparison between Efavirenz and Nevirapine Using Inverse Probability Weighting. Antiviral Therapy.


Chicago/Turabian   Click to copy
Hermans, S., Y. Manabe, A. Kiragga, A. Hoepelman, J. Lange, and F. van Leth. “Risk of Tuberculosis after Antiretroviral Treatment Initiation: A Comparison between Efavirenz and Nevirapine Using Inverse Probability Weighting.” Antiviral Therapy (2013).


MLA   Click to copy
Hermans, S., et al. “Risk of Tuberculosis after Antiretroviral Treatment Initiation: A Comparison between Efavirenz and Nevirapine Using Inverse Probability Weighting.” Antiviral Therapy, 2013.


BibTeX   Click to copy

@article{s2013a,
  title = {Risk of Tuberculosis after Antiretroviral Treatment Initiation: A Comparison between Efavirenz and Nevirapine Using Inverse Probability Weighting},
  year = {2013},
  journal = {Antiviral Therapy},
  author = {Hermans, S. and Manabe, Y. and Kiragga, A. and Hoepelman, A. and Lange, J. and van Leth, F.}
}


Share

Tools
Translate to